Uncovering the underlying causes of Parkinson's disease

April 3, 2014 by Angelo Risso, University of Technology, Sydney
Recreation of dopamine (purple) and iron (teal) distribution in the mouse midbrain. Credit: Ethix Design

(Medical Xpress)—A breakthrough investigation by UTS researchers into the underlying causes of Parkinson's disease has brought us a step closer to understanding how to manage the condition.

The team, led by UTS postdoctoral fellow Dr Dominic Hare and Professor Philip Doble, has produced the first empirical evidence that an imbalance of and dopamine in the substantia nigra pars compacta (SNc) region of the is the root cause of the neurodegenerative condition.

Caused by the slow loss of neurons in the SNc that control autonomous movement, Parkinson's disease causes persistent shaking, gastrointestinal problems and a variety of other ailments.

More than 80,000 Australians suffer from the illness, most over the age of 60.

Hare's findings, before only assumptions in the scientific community, finally validate the theory that iron and dopamine react to create free radicals in the brain that slowly destroy neuron pathways and bring about the onset of Parkinson's.

"When these two chemicals react, it forms a toxic species of dopamine that essentially reacts like bleach in the brain," said Hare.

To conduct their research Hare and his team used a unique tagging technique using antibodies labelled with gold nanoparticles that acted as proxies for dopamine molecules. This enabled the team to monitor and "co-localise" metals with other molecules and proteins in the brain.

And the findings of this work, said Hare, were revelatory.

Dominic Hare. Credit: Carmen Lee Spiers

"What we found is those particular cells (in the SNc) have what you could call an 'anti-Goldilocks effect' – they have just the right amount of iron and just the right amount of to cause damage," said Dr Hare.

"When we give mice a toxin that mimics the effects of Parkinson's disease, these cells degenerate."

Hare theorises that this effect is likely a natural result of aging, when the brain's ability to securely store iron diminishes and allows iron molecules to "leak" into critical areas such as the SNc.

Finding ways to design drugs that can get into the brain and eliminate surplus iron – an initiative that is already well underway in the process of treating other illnesses like cancer and Alzheimer's disease – is now the next step forward in research.

Preventative measures to halt the build-up of iron in the brain as humans undergo the aging process are also touted by Hare as an important next step, and is something he is now working on.

"I think the real hope is, while we might not necessarily find a cure, prevention is actually not that far away," said Hare.

"So it's a case where you can wake up and say, 'my Parkinson's is flaring up again', take a tablet and go about your business."

Explore further: Using rabies virus, researcher tracks inputs to dopamine neurons

More information: "An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta." Dominic J. Hare, et al. Chem. Sci., 2014, Advance Article, DOI: 10.1039/C3SC53461H

Related Stories

Using rabies virus, researcher tracks inputs to dopamine neurons

June 6, 2012
A genetically-modified version of the rabies virus is helping scientists at Harvard to trace neural pathways in the brain, a research effort that could one day lead to treatments for Parkinson's disease and addiction.

Ultra-high-field MRI may allow earlier diagnosis of Parkinson's disease

March 5, 2014
New research shows that ultra-high-field magnetic resonance imaging (MRI) provides detailed views of a brain area implicated in Parkinson's disease, possibly leading to earlier detection of a condition that affects millions ...

Stress-induced depression exacerbates Parkinson's

March 6, 2014
(Medical Xpress)—Chronic stress-induced depression exacerbated an experimental model of Parkinson's disease, researchers at the University of Cincinnati (UC) have shown.

'Big Science' uncovers another piece in the Alzheimer's puzzle

March 26, 2014
In a paper published today, British scientists have found evidence that  biological material contributing to lesions in the brain, characteristic in Alzheimer's patients, may also cause the build-up of brain-cell-damaging ...

Recommended for you

Parkinson's disease 'jerking' side effect detected by algorithm

January 8, 2018
A mathematical algorithm that can reliably detect dyskinesia, the side effect from Parkinson's treatment that causes involuntary jerking movements and muscle spasms, could hold the key to improving treatment and for patients ...

New brainstem changes identified in Parkinson's disease

January 4, 2018
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Researchers shed light on why exercise slows progression of Parkinson's disease

December 22, 2017
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.

Robotic device improves balance and gait in Parkinson's disease patients

December 19, 2017
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years ...

New findings point to potential therapy for Parkinson's Disease

December 19, 2017
A new study, published in Proceedings of the National Academy of Sciences (PNAS), sheds light on a mechanism underlying Parkinson's disease and suggests that Tacrolimus—an existing drug that targets the toxic protein interaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.